Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY10.69 CNY
Change Today -0.51 / -4.55%
Volume 20.6M
600713 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for nanjing pharmaceutical co-a (600713)

Year over year, NanJing Pharmaceutical Company Limited has been able to grow revenues from CNY19.2B CNY to CNY22.0B CNY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 4.42% to 3.98%. This was a driver that led to a bottom line growth from CNY38.7M CNY to CNY128.9M CNY.
View Income Statement In U.S. Dollar
Currency in
Millions of Chinese Renminbi (Yuan)s
As of:Dec 31
2011
Restated
CNY
Dec 31
2012
Reclassified
CNY
Dec 31
2013
Restated
CNY
Dec 31
2014
CNY
4 Year
Trend
Revenues17,100.717,834.719,184.822,018.3
Other Revenues61.454.651.157.5
TOTAL REVENUES17,171.718,024.219,235.922,075.8
Cost of Goods Sold15,982.616,667.718,026.220,746.9
GROSS PROFIT1,189.11,356.51,209.71,328.9
Selling General & Admin Expenses, Total1,114.61,016.8848.9876.5
Other Operating Expenses42.162.139.246.1
OTHER OPERATING EXPENSES, TOTAL1,156.71,078.9888.2922.6
OPERATING INCOME32.5277.6321.5406.3
Interest Expense-305.5-329.5-262.2-305.8
Interest and Investment Income148.0163.6101.885.1
NET INTEREST EXPENSE-157.5-165.9-160.4-220.7
Currency Exchange Gains (Loss)0.0-0.1-0.2-0.1
Other Non-Operating Income (Expenses)-18.9-13.7-17.9-5.0
EBT, EXCLUDING UNUSUAL ITEMS-143.997.9143.0180.5
Impairment of Goodwill-3.8------
Gain (Loss) on Sale of Investments-1.4-1.1----
Gain (Loss) on Sale of Assets6.2114.322.215.1
Other Unusual Items, Total-7.0-153.4-36.68.5
Legal Settlements------11.0
Other Unusual Items6.1-16.42.3-2.6
EBT, INCLUDING UNUSUAL ITEMS-150.057.8128.7204.0
Income Tax Expense33.563.063.551.6
Minority Interest in Earnings0.816.0-26.5-23.5
Earnings from Continuing Operations-183.5-5.265.2152.4
NET INCOME-182.610.838.7128.9
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-182.610.838.7128.9
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-182.610.838.7128.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600713:CH CNY10.69 CNY -0.51

600713 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY71.48 CNY 0.00
Jointown Pharmaceutical Group Co Ltd CNY20.77 CNY +0.58
Shanghai Pharmaceuticals Holding Co Ltd CNY20.44 CNY +0.52
Wanjia Group Holdings Ltd $0.81 HKD -0.01
View Industry Companies
 

Industry Analysis

600713

Industry Average

Valuation 600713 Industry Range
Price/Earnings 64.8x
Price/Sales 0.4x
Price/Book 4.6x
Price/Cash Flow 60.3x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANJING PHARMACEUTICAL CO-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.